News Releases

2006

XXX
Dec.19,2006
Announcement of the Launch of Elaspol® 100 for Injection for Acute Lung Injury Associated with SIRS in Korea (49.1KB)
XXX
Oct.26,2006
Ono Enters into License Agreement with Sapphire Therapeutics, Inc. in Japan,Korea and Taiwan - New Drug for the Treatment of Cancer Anorexia/Cachexia - (71.1KB)
XXX
Oct.25,2006
Announcement of Approval of Additional Indications for Onoact® 50 for Injection, Short-Acting Selective β1 Blocker (93.9KB)
XXX
Oct.23,2006
Merck & Co, Inc. Announced Approval of JANUVIA™ (INN: sitagliptin),a new oral treatment of diabetes, by the US FDA (132KB)
XXX
Oct.02,2006
Announcement on Acquisition of the CompanyÂfs Own Shares (pursuant to the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Corporate Law of Japan) (58.0KB)
XXX
Aug.04,2006
Revisions of the Interim and Full Year Business Forecasts for FY2006 (83.4KB)
XXX
Aug.04,2006
Investigational New Class of Oral Medication for Patients with Type 2 Diabetes, Sitagliptin (a DPP-4 inhibitor), Begins Phase III Clinical Trials in Japan (35.0KB)
XXX
Aug.01,2006
Allowance of an investigational new drug application (IND) for ONO-4538 / MDX-1106, a fully human anti-PD-1 antibody (106KB)
XXX
Jul.20,2006
Results of Phase II / III Studies of Rivastigmine Patch, the World's First Transdermal Therapy for Alzheimer's Disease, Were Presented at OCAD (184KB)
XXX
Jul.10,2006
Application Filed for the Osteoporosis Treatment ONO-5920/YM529 in Japan (73.0KB)
XXX
Jul.07,2006
Ono Entered Into Drug Discovery Agreement on Kinases with Locus Pharmaceuticals, Inc. (17.3KB)
XXX
Jun.14,2006
Results of Phase III Studies of Sitagliptin, new oral treatment of diabetes, were presented by Merck & Co., Inc. at ADA (The 2nd Announcement) (120KB)
XXX
Jun.12,2006
Results of Phase III Studies of Sitagliptin, new oral treatment of diabetes,were presented by Merck & Co., Inc. at ADA (260KB)
XXX
May.15,2006
Announcement on Change of Audit Corporation (7.9KB)
XXX
May.15,2006
Introduction of Interim dividend (7.7KB)
XXX
May.15,2006
Announcement on Changes of Representative Directors and Members of the Board of Directors (57.6KB)
XXX
Apr.06,2006
Announcement on Changes of Members of the Board of Directors (51.5KB)
XXX
Mar.28,2006
Entered Into New Collaborative Research Agreement with Medarex for Antibody Product (76.9KB)
XXX
Mar.22,2006
Licensing Agreement on PDE4 Inhibitor ONO-6126 (61.2KB)
XXX
Mar.06,2006
Ono resolved increase in dividends projected for the fiscal year 2005 (ending on March 31st,2006) (137KB)